Gelofusine balanced
DrugGelofusine balanced combined with Sterofundin ISO
NCT Number: NCT01515397
The aim of volume replacement is to compensate a reduction in the intravascular volume e.g. during surgery and to counteract hypovolemia in order to maintain hemodynamics and vital functions. To achieve this, different plasma substitutes are available: Albumin, dextran, hydroxyethylstarches and gelatine. The aim of this study is to demonstrate that acid-base alterations during elective abdominal surgery can be reduced by the use of a new gelatine solution.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 3
Universitätsklinikum Aachen, Klinik für Anästhesiologie, Aachen, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion:
Exclusion:
Gelofusine balanced combined with Sterofundin ISO
Gelofusine 4% combined with NaCl 0.9%
Time frame: Change from baseline at end of surgery, an expected average of 2 hours surgery
Time frame: Change from baseline at end of surgery, an expected average of 2 hours surgery
Time frame: until 12 hours after surgery
Time frame: until 12 hours after surgery
Time frame: until 12 hours after surgery
Time frame: until 12 hours after surgery
Time frame: until 12 hours after surgery
Time frame: until 12 hours after surgery
B. Braun Melsungen AG
Industry
Efficacy and Safety of a Balanced Gelatine Solution in Combination With a Balanced Electrolyte Solution Versus a Standard Gelatine Solution in Combination With a Non-balanced Electrolyte Solution in Patients Scheduled for Abdominal Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04186416
Fluid Responsiveness, Hemorrhage
Paris, France
View Trial DetailsNCT05705115
Fluid Loss, Hemodynamic Instability
Oslo, Norway
View Trial DetailsNCT05054452
Critical Illness, Disease Attributes
Le Kremlin-Bicêtre, France
View Trial DetailsNCT02193412
Hypovolemia, Neurologic Manifestations
Lille, Nord, France
View Trial Details